Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 69 for “"EBOV"”.
-
Development of an EBOV-GP virus entry system and investigation of the anti-EBOV activity of an extract of Prunella vulgaris and Investigation of the regulatory role of IL-34 in macrophages and CD4+ T lymphocytes during HIV-1 infection
In this study, we developed an EBOV-glycoprotein (GP) pseudotyped HIV-1-based vector system for the screening of anti-EBOV-GP agent(s). Based on this system, we demonstrated that an aqueous extract (CHPV) from the Chinese herb Prunella vulgaris displayed a potent inhibitory effect on EBOV-GP …
-
Longitudinal histopathological, immunohistochemical, and In Situ hybridization analysis of host and viral biomarkers in liver tissue sections of Ebola (EBOV) infected rhesus macaques
INTRODUCTION: Ebola virus (EBOV) is a highly infectious and often lethal filovirus that causes hemorrhagic fever, with a reported case fatality rate of 40-90%. There are currently no Food and Drug Administration (FDA) approved medical countermeasures (MCMs) for EBOV. Non-human primates (NHPs) …
-
Cell-to-cell infection, cell-cell fusion and production of ebolavirus : mechanisms of action and cellular modulators
Ebolavirus (EBOV), a member of the Filoviridae family, is a deadly non-segment negative-sense RNA virus that causes hemorrhagic fever among human and other species; the fatality rate can be up to 80%. In 2014, a re-emergent and serious outbreak of EBOV occurred in West Africa, which had claimed …
-
Identification and characterisation of innate antiviral proteins with activity against <i>Ebolaviruses</i>
Ebola virus (EBOV), a negative sense RNA virus, encodes seven structural proteins of which two, VP35 and VP24 have developed mechanisms to evade and antagonise the interferon system. VP35 antagonises the RNA sensing pathway, whereas VP24 antagonises downstream interferon signalling by inhibition of …
-
Sphingomyelinases and Lysosomal Trafficking in Ebolavirus Entry
Ebolavirus (EBOV) is a negative sensed, single-strand filovirus which causes up to 90% mortality. Despite increasing outbreaks over the past decade, no approved vaccines or therapies exist. One drug treatment strategy is to target virus entry mechanisms. EBOV enters the cell using a …
-
Ebola virus induces a type I interferon response in induced pluripotent stem cell derived hepatocytes
Ebola virus (EBOV) infection causes a severe disease in humans and leads to widespread liver necrosis, a dysregulated cytokine response, and coagulopathy. However, little is known about the specific liver response to EBOV infection in humans. Here we present the utilization of an induced …
-
Identification of Signaling Pathways Involved in Ebola Virus Entry Into Host Cells
Ebola virus (EBOV) is an enveloped virus of the family Filoviridae that causes outbreaks of hemorrhagic fever and for which there are no FDA-approved antiviral therapies. EBOV entry involves internalization and trafficking within host cells to facilitate delivery of the virus to its intracellular …
-
Characterization of Trafficking Factors Involved in Ebola Virus Entry
Ebola virus (EBOV) and other members of the Filoviridae family are enveloped RNA viruses that are the causative agents of sporadic outbreaks of highly lethal disease in humans and non-human primates. EBOV entry into host cells requires attachment, internalization, and subsequent trafficking to the …
-
Characterization of immune responses correlating with protection and the development of an efficacious treatment against Ebola virus infections
Ebola virus (EBOV) is a zoonotic pathogen which causes a fulminant hemorrhagic fever and results in up to 90% fatality. Despite efforts over the past 38 years, a licensed prophylactic or post-exposure option remains unavailable. Several experimental vaccines have already demonstrated protection …
-
Characterisation and application of an ebola virus glycoprotein pseudotyped influenza virus (E-S-Flu)
<p>Ebola virus (EBOV) is a single-stranded RNA virus from the Filoviridae family. It is a biosafety level 4 pathogen, and infection causes fatal haemorrhagic fever in humans, yet no approved vaccines or therapeutics are available.</p> <p>We describe a new EBOV surrogate, E-S-FLU, a single-cycle …
-
INVESTIGATING HOST REGULATION OF THE FILOVIRUS LIFECYCLE
Filoviruses Ebola (EBOV) and Marburg (MARV) are emerging pathogens capable ofcausing explosive outbreaks with high mortality rates. Host proteins play critical roles in regulating (positively or negatively) EBOV and MARV entry and exit, and their identification can provide biological and …
-
Adipose tissue is a target for Ebola virus, having systemic implications in metabolism and stress during acute and prolonged infection
The geographical range of Ebola virus (EBOV) outbreaks overlaps with the habitat of diverse ecosystems that are home to many potential reservoir species. Although researchers have discovered EBOV viral RNA and serological evidence in different rodents and bats, live virus has not been isolated from …
-
Sero-prevalence of Ebola and Lassa virus in the Republic of Guinea, Macenta prefecture
Following the 2013-2016 West Africa Ebolavirus (EBOV) outbreak, a broad range of scientific research has been conducted to understand and prevent future epidemics. Our current study, supported by the United States Food and Drug Administration (FDA), uses sero-epidemiology to look at the foot-print …
-
Ebola virus nucleocapsid-like particles demonstrate consistent assembly, but a wide range of helical condensation
… to determine whether envelope-free Ebola virus (EBOV) nucleocapsids could be isolated. We identified novel structures from EBOV infected cells that we have termed “proto-nucleocapsids”. These proto-nucleocapsids were ~30.5 nm in diameter and single particle image analysis revealed a hollow …
-
Bundibugyo Versus Zaire Ebolaviruses: Examination of the Polymerase Complex as a Therapeutic Target
… in geographic distribution: Zaire ebolavirus (EBOV), Sudan ebolavirus (SUDV), and Bundibugyo ebolavirus (BDBV). EBOV and BDBV are distinctly different in case-fatality rate, disease course, and clinical presentation in both humans and non-human primates, but the reasons for these differences …
-
Generation and characterization of a live, bivalent vaccine against human immunodeficiency virus and Ebola virus
… its Envelope protein (Env), while Ebola virus (EBOV) causes a lethal hemorrhagic fever and targets antigen presenting cells (APCs) via its glycoprotein (GP). There are no licensed vaccines for either virus, posing a problem particularly in Africa, where succumbing to EBOV or HIV is a grim …
-
Description of interactions of Ebola virus with a putative reservoir species using next-generation sequencing
Ebola virus (EBOV) causes a severe, often fatal disease in humans and nonhuman primates. Recently, EBOV has caused two very large outbreaks, one of which is ongoing in the Democratic Republic of the Congo. Bats are the likely reservoir of EBOV, but little is known of their relationship with the …
-
Ebola virus RNA editing:Characterization of the mechanism and gene products
Ebola virus (EBOV) is an enveloped, negative-sense single-stranded RNA virus that causes severe hemorrhagic fever in humans and nonhuman primates. The EBOV glycoprotein (GP) gene encodes multiple transcripts due to RNA editing at a conserved editing site (ES) (a hepta-uridine stretche). The …
-
Examination of the cellular stress response and post-transcriptional regulation of RNA during Ebola virus infection
Ebola virus (EBOV) causes severe disease in humans characterized by high case fatality rates and significant immune dysfunction. A hallmark of EBOV infection is the formation of viral inclusions in the cytoplasm of infected cells. These inclusions contain the EBOV nucleocapsids and are sites of …
-
Antibody-based diagnostics and therapeutics for Zaire ebolavirus and Burkholderia pseudomallei
Zaire ebolavirus (EBOV) and Burkholderia pseudomallei are the causative agents of Ebola virus disease (EVD) and melioidosis, respectively. Early diagnosis is critical for halting the spread of the disease or providing treatment of the disease. Current diagnosis for EBOV includes polymerase chain …
Page 1 of 4